GSA Capital Partners’s HilleVax HLVX Stock Holding History

GSA Capital Partners’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,466	Closed	-$156K	–	1848
2025 Q2	$156K	Buy	78,466 +54,914	+233%	+$100K	0.01%	1561
2025 Q1	$34K	Sell	23,552 -44,277	-65%	-$81.8K	﹤0.01%	1565
2024 Q4	$140K	Sell	67,829 -3,634	-5%	-$6.82K	0.01%	1481
2024 Q3	$126K	Buy	+71,463	New	+$183K	0.01%	1469

GSA Capital Partners's HLVX Position: Q3 2025 in Review

GSA Capital Partners sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 78,466 shares — an estimated $156K sold.

GSA Capital Partners first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $156K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

GSA Capital Partners reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
GSA Capital Partners sold 78,466 HilleVax shares in Q3 2025, an estimated $156K.
GSA Capital Partners first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
GSA Capital Partners's HilleVax position peaked at $156K in Q2 2025.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.